logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11267823 B1

PDFFull Text
Date of Patent:
Mar. 08, 2022

Filed:

Jul. 09, 2020

Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1',2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having hiv integrase inhibitory activity

Applicants:

Shionogi & Co., Ltd., Osaka, JP;

Viiv Healthcare Company, Wilmington, DE (US);

Inventors:

Brian A. Johns, Research Triangle Park, NC (US);

Takashi Kawasuji, Osaka, JP;

Teruhiko Taishi, Osaka, JP;

Yoshiyuki Taoda, Osaka, JP;

Assignees:

SHIONOGI & CO., LTD., Osaka, JP;

VIIV HEALTHCARE COMPANY, Research Triangle Park, NC (US);

Attorney:

Wenderoth, Lind & Ponack, L.L.P.

Primary Examiner:

Douglas M Willis

Int. Cl.
CPC ...
A61K 31/4985 (2006.01); C07D 487/22 (2006.01); C07D 498/14 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 498/04 (2006.01); C07D 471/22 (2006.01); C07D 498/20 (2006.01); C07D 498/22 (2006.01); A61K 31/5365 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/519 (2006.01); A61K 31/551 (2006.01);
U.S. Cl.
CPC ...
C07D 498/14 (2013.01); A61K 9/0053 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/5365 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01); C07D 471/14 (2013.01); C07D 471/22 (2013.01); C07D 498/04 (2013.01); C07D 498/20 (2013.01); C07D 498/22 (2013.01);
Abstract

Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1',2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a pharmaceutical composition containing the same, particularly an anti-HIV pharmaceutical composition.

Find Patent Forward Citations

Johns, Brian. (2022). Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1',2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having hiv integrase inhibitory activity (U.S. Patent No. 11267823). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11267823

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…